BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9

• Press Releases

  Hemab Therapeutics Receives FDA Breakthrough Therapy Designation for Sutacimig in Glanzmann Thrombasthenia

  March 5, 2026

   · 

  4 min read
• Press Releases

  Medicus Pharma Reports Positive Phase 2 SKNJCT-003 Topline Data Observing 73% Clinical Clearance and 40% Histological Clearance (CR) at Day 57 in 200μg Cohort

  March 5, 2026

   · 

  11 min read
• Press Releases

  CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

  March 5, 2026

   · 

  14 min read
• Press Releases

  Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder

  March 5, 2026

   · 

  9 min read
• Press Releases

  Zevra Therapeutics Appoints Justin Renz as Chief Financial Officer

  March 5, 2026

   · 

  3 min read
• Press Releases

  Repligen Corporation to Present at Upcoming March 2026 Conferences

  March 5, 2026

   · 

  1 min read
• Press Releases

  CervoMed to Participate in Upcoming March 2026 Investor Conferences

  March 5, 2026

   · 

  1 min read
• Press Releases

  Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences

  March 5, 2026

   · 

  9 min read
• Press Releases

  Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results

  March 5, 2026

   · 

  10 min read
• Press Releases

  SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI

  March 5, 2026

   · 

  9 min read